These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11509953)

  • 1. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Ruffini F; Furlan R; Poliani PL; Brambilla E; Marconi PC; Bergami A; Desina G; Glorioso JC; Comi G; Martino G
    Gene Ther; 2001 Aug; 8(16):1207-13. PubMed ID: 11509953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes.
    Furlan R; Brambilla E; Ruffini F; Poliani PL; Bergami A; Marconi PC; Franciotta DM; Penna G; Comi G; Adorini L; Martino G
    J Immunol; 2001 Aug; 167(3):1821-9. PubMed ID: 11466408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity.
    Nygårdas M; Paavilainen H; Müther N; Nagel CH; Röyttä M; Sodeik B; Hukkanen V
    PLoS One; 2013; 8(5):e64200. PubMed ID: 23700462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination.
    Furlan R; Poliani PL; Galbiati F; Bergami A; Grimaldi LM; Comi G; Adorini L; Martino G
    Hum Gene Ther; 1998 Nov; 9(17):2605-17. PubMed ID: 9853527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice.
    Furlan R; Poliani PL; Marconi PC; Bergami A; Ruffini F; Adorini L; Glorioso JC; Comi G; Martino G
    Gene Ther; 2001 Jan; 8(1):13-9. PubMed ID: 11402297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
    Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach.
    Martino G; Poliani PL; Furlan R; Marconi P; Glorioso JC; Adorini L; Comi G
    J Neuroimmunol; 2000 Jul; 107(2):184-90. PubMed ID: 10854655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
    Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis.
    Poliani PL; Brok H; Furlan R; Ruffini F; Bergami A; Desina G; Marconi PC; Rovaris M; Uccelli A; Glorioso JC; Penna G; Adorini L; Comi G; 't Hart B; Martino G
    Hum Gene Ther; 2001 May; 12(8):905-20. PubMed ID: 11387056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors.
    Martino G; Poliani PL; Marconi PC; Comi G; Furlan R
    Gene Ther; 2000 Jul; 7(13):1087-93. PubMed ID: 10918474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination.
    Pennati A; Nylen EA; Duncan ID; Galipeau J
    J Neurosci; 2020 Jun; 40(26):5105-5115. PubMed ID: 32430295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
    Mokhtarian F; Safavi F; Sarafraz-Yazdi E
    Brain Res; 2012 Dec; 1488():92-103. PubMed ID: 23031637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation.
    Rajendran R; Giraldo-Velásquez M; Stadelmann C; Berghoff M
    Brain Pathol; 2018 Mar; 28(2):212-224. PubMed ID: 28117910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligodendrocyte-Specific Deletion of
    Rajendran R; Rajendran V; Giraldo-Velasquez M; Megalofonou FF; Gurski F; Stadelmann C; Karnati S; Berghoff M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA; Lee DH; Demir S; Wiese S; Kruse N; Siglienti I; Gerhardt E; Neumann H; Sendtner M; Lühder F; Gold R
    Brain; 2010 Aug; 133(Pt 8):2248-63. PubMed ID: 20826430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
    Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE).
    Munro KM; Dixon KJ; Gresle MM; Jonas A; Kemper D; Doherty W; Fabri LJ; Owczarek CM; Pearse M; Boyd AW; Kilpatrick TJ; Butzkueven H; Turnley AM
    PLoS One; 2013; 8(2):e55948. PubMed ID: 23390555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
    Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of Experimental Autoimmune Encephalomyelitis in Mice by Interferon-Beta Gene Therapy, Using a Long-Term Expression Plasmid Vector.
    Hamana A; Takahashi Y; Tanioka A; Nishikawa M; Takakura Y
    Mol Pharm; 2017 Apr; 14(4):1212-1217. PubMed ID: 28257578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.